These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26080370)

  • 1. Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants.
    Nunes MC; Cutland CL; Dighero B; Bate J; Jones S; Hugo A; van Niekerk N; Kuwanda L; Izu A; Weinberg A; Madhi SA;
    J Infect Dis; 2015 Dec; 212(12):1976-87. PubMed ID: 26080370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccination of pregnant women and protection of their infants.
    Madhi SA; Cutland CL; Kuwanda L; Weinberg A; Hugo A; Jones S; Adrian PV; van Niekerk N; Treurnicht F; Ortiz JR; Venter M; Violari A; Neuzil KM; Simões EA; Klugman KP; Nunes MC;
    N Engl J Med; 2014 Sep; 371(10):918-31. PubMed ID: 25184864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women.
    Abzug MJ; Nachman SA; Muresan P; Handelsman E; Watts DH; Fenton T; Heckman B; Petzold E; Weinberg A; Levin MJ;
    Clin Infect Dis; 2013 May; 56(10):1488-97. PubMed ID: 23378284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial.
    Nunes MC; Cutland CL; Moultrie A; Jones S; Ortiz JR; Neuzil KM; Klugman KP; Simões EAF; Weinberg A; Madhi SA;
    Lancet HIV; 2020 Feb; 7(2):e91-e103. PubMed ID: 31911146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial.
    Vesikari T; Virta M; Heinonen S; Eymin C; Lavis N; Chabanon AL; Gresset-Bourgeois V
    Hum Vaccin Immunother; 2020 Mar; 16(3):623-629. PubMed ID: 31526225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.
    Munoz FM; Patel SM; Jackson LA; Swamy GK; Edwards KM; Frey SE; Petrie CR; Sendra EA; Keitel WA
    Vaccine; 2020 Jul; 38(33):5355-5363. PubMed ID: 32571718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn.
    Blanchard-Rohner G; Meier S; Bel M; Combescure C; Othenin-Girard V; Swali RA; Martinez de Tejada B; Siegrist CA
    Pediatr Infect Dis J; 2013 Dec; 32(12):1374-80. PubMed ID: 24569309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants.
    D'Angio CT; Heyne RJ; Duara S; Holmes LC; O'Shea TM; Wang H; Wang D; Sánchez PJ; Welliver RC; Ryan RM; Schnabel KC; Hall CB;
    Pediatr Infect Dis J; 2011 Jul; 30(7):570-4. PubMed ID: 21273938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study.
    Nakphook S; Patumanond J; Shrestha M; Prasert K; Chittaganpitch M; Mott JA; Praphasiri P
    PLoS One; 2021; 16(6):e0253028. PubMed ID: 34106994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial.
    Mutsaerts E; Madhi SA; Cutland CL; Jones S; Hugo A; Trenor S; Treurnicht FK; Klipstein-Grobusch K; Weinberg A; Nunes MC
    Expert Rev Vaccines; 2016 Aug; 15(8):1055-62. PubMed ID: 27212228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial.
    Tsatsaris V; Capitant C; Schmitz T; Chazallon C; Bulifon S; Riethmuller D; Picone O; Poulain P; Lewin F; Lainé F; Jacqz-Aigrain E; Aboulker JP; Launay O;
    Ann Intern Med; 2011 Dec; 155(11):733-41. PubMed ID: 22147712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease.
    Jallow S; Cutland CL; Masbou AK; Adrian P; Madhi SA
    J Clin Virol; 2017 Sep; 94():50-56. PubMed ID: 28759772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccination during pregnancy and its usefulness to mothers and their young infants.
    Takeda S; Hisano M; Komano J; Yamamoto H; Sago H; Yamaguchi K
    J Infect Chemother; 2015 Apr; 21(4):238-46. PubMed ID: 25708925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.
    Christian LM; Beverly C; Mitchell AM; Karlsson E; Porter K; Schultz-Cherry S; Ramilo O
    Vaccine; 2017 Sep; 35(39):5283-5290. PubMed ID: 28778612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials.
    Madhi SA; Nunes MC; Weinberg A; Kuwanda L; Hugo A; Jones S; van Niekerk N; Ortiz JR; Neuzil KM; Klugman KP; Simões EAF; Cutland CL;
    Clin Infect Dis; 2017 Jun; 64(12):1773-1779. PubMed ID: 28369198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of HIV-infected pregnant women: implications for protection of their young infants.
    Dangor Z; Nunes MC; Kwatra G; Lala SG; Madhi SA
    Trop Dis Travel Med Vaccines; 2017; 3():1. PubMed ID: 28883971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.
    Cadorna-Carlos JB; Nolan T; Borja-Tabora CF; Santos J; Montalban MC; de Looze FJ; Eizenberg P; Hall S; Dupuy M; Hutagalung Y; Pépin S; Saville M
    Vaccine; 2015 May; 33(21):2485-92. PubMed ID: 25843270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women.
    Nunes MC; Weinberg A; Cutland CL; Jones S; Wang D; Dighero-Kemp B; Levine MZ; Wairagkar N; Madhi SA
    PLoS One; 2018; 13(12):e0210124. PubMed ID: 30596775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.
    Munoz FM; Jackson LA; Swamy GK; Edwards KM; Frey SE; Stephens I; Ault K; Winokur P; Petrie CR; Wolff M; Patel SM; Keitel WA
    Vaccine; 2018 Dec; 36(52):8054-8061. PubMed ID: 30416018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.